ARTICLE | Clinical News
Avastin bevacizumab regulatory update
December 7, 2009 8:00 AM UTC
Ontario's Ministry of Health and Long-Term Care said it renegotiated pricing for Roche's Avastin bevacizumab, which the agency's New Drug Funding Program will now cover for up to 24 cycles, up from 16...